Department of Clinical Psychology, Faculty of Social and Behavioural Sciences, Utrecht University, Utrecht, The Netherlands.
ARQ National Psychotrauma Centre, Diemen, The Netherlands.
Eur J Psychotraumatol. 2021 Nov 24;12(1):1987687. doi: 10.1080/20008198.2021.1987687. eCollection 2021.
Losing a loved one during the COVID-19 pandemic is a potentially traumatic loss that may result in symptoms of persistent complex bereavement disorder (PCBD), posttraumatic stress disorder (PTSD), and depression. To date, grief-specific cognitive-behavioural therapy (CBT) has mostly been delivered through individual face-to-face formats, while studies have shown that online treatment also yields promising results. Offering treatment online is now more than ever relevant during the pan demic and may offer important benefits compared with face-to-face CBT, such as lower costs and higher accessibility. Our expectation is that grief-specific online CBT is effective in reducing PCBD, PTSD, and depression symptoms.
Our aim is to evaluate the short-term and long-term effectiveness of grief-specific online CBT in reducing PCBD, PTSD, and depression symptom-levels for adults who lost a loved one during the COVID-19 pandemic.
This study consists of two parts. In part 1, a two-armed (unguided online CBT versus waitlist controls) randomized controlled trial will be conducted. In part 2, a two-armed (guided online CBT versus unguided online CBT) controlled trial will be conducted. Symptoms of PCBD, PTSD, and depression will be assessed via telephone interviews at pre-treatment/pre-waiting period, post-treatment/post-waiting period, and six months post-treatment. Potential participants are people who lost a loved one at least three months earlier during the COVID-19 pandemic with clinically relevant levels of PCBD, PTSD, and/or depression. Analysis of covariance and multilevel modelling will be performed.
This is one of the first studies examining the effectiveness of online grief-specific CBT. More research is needed before implementing online grief-specific CBT into clinical practice.
在 COVID-19 大流行期间失去亲人是一种潜在的创伤性丧失，可能导致持续性复杂丧亲障碍（PCBD）、创伤后应激障碍（PTSD）和抑郁症状。迄今为止，针对悲伤的认知行为疗法（CBT）主要通过个体面对面的形式提供，而研究表明，在线治疗也能产生有前景的结果。在大流行期间，在线提供治疗比以往任何时候都更加相关，并且可能与面对面 CBT 相比具有重要优势，例如成本更低、可及性更高。我们期望特定于悲伤的在线 CBT 能够有效降低 PCBD、PTSD 和抑郁症状。
我们的目的是评估针对 COVID-19 大流行期间失去亲人的成年人的特定于悲伤的在线 CBT 在短期和长期内降低 PCBD、PTSD 和抑郁症状水平的有效性。
这项研究由两部分组成。在第一部分中，将进行一项两臂（无指导在线 CBT 与等待对照）随机对照试验。在第二部分中，将进行一项两臂（有指导在线 CBT 与无指导在线 CBT）对照试验。通过电话访谈在治疗前/等待期、治疗后/等待期和治疗后六个月评估 PCBD、PTSD 和/或抑郁症状。潜在参与者是在 COVID-19 大流行期间至少三个月前失去亲人且 PCBD、PTSD 和/或抑郁症状具有临床相关性的人。将进行协方差分析和多层次建模。
这是第一项研究在线特定于悲伤的 CBT 有效性的研究之一。在将在线特定于悲伤的 CBT 纳入临床实践之前，还需要更多的研究。
